Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical tria...
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Chronic obstructive pulmonary disease (COPD) is characterised by progressive airflow limitation and chronic inflammation. Predicting exacerbations of COPD, which contribute to disease progression, is important to guide preventative treatment and improve outcomes. Blood eosinophils are a biomarker for patient responsiveness to inhaled corticosteroid...
Alternative Titles
Full title
Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1428768bef3040f9ab20ab19592abf68
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1428768bef3040f9ab20ab19592abf68
Other Identifiers
ISSN
1465-993X,1465-9921
E-ISSN
1465-993X,1465-9921
DOI
10.1186/s12931-020-01482-1
